We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA expects companies to identify trends while analyzing their quality data — and to act on what they learn. In other words, the FDA expects companies to do more than provide the agency a look back at data and an after-the-fact reaction to quality problems. Companies must use trending techniques to catch — and address — quality problems early.